.png){kind=icon}
.png){kind=icon}
Return
Application of adipose-derived stem cells in treating fibrosis
.png){kind=icon}
OA
AI
Z
L
Y
C
J
N
X
DOI：10.4252/wjsc.v13.i11.1747.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Fibrosis is the hyperactivation of fibroblasts that results in excessive accumulation of extracellular matrix, which is involved in numerous pathological changes and diseases. Adipose-derived stem cells (ASCs) are promising seed cells for regenerative medicine due to their bountiful source, low immunogenicity and lack of ethical issues. Their anti-fibrosis, immunomodulation, angiogenesis and other therapeutic effects have made them suitable for treating fibrosis-related diseases. Here, we review the literature on ASCs treating fibrosis, elaborate and discuss their mechanisms of action, changes in disease environment, ways to enhance therapeutic effects, as well as current preclinical and clinical studies, in order to provide a general picture of ASCs treating fibrotic diseases.
Keywords:
Adipose-derived stem cells
Fibrosis
Immunomodulation
Modification
Therapeutic effect
Clinical trials
Journal
IF:
3.6
Papers:
827
Citations:
2.8K
Organization
Cited Papers